Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus tablets for oral suspension indicated for patients with tuberous ...

On 11 March 2015, Natco Pharma announced that it is the first company in India to get approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General (India). Natco will market ...

Also read: Front-end manufacturing in U.S. way forward to counter tariff impact on pharma: Natco Pharma CEO Aurobindo Pharma, Dr. Reddy’s Laboratories, Sun Pharma, Lupin, Cipla, Natco Pharma ...